Treatment of DIC with Active Bleeding or High Risk of Bleeding
Patients with disseminated intravascular coagulation (DIC) who are actively bleeding — or at high risk due to recent surgery or an upcoming invasive procedure — require a distinct management approach guided by laboratory findings and clinical context.
Clinical Scenario
DIC presenting with active bleeding, or in patients at elevated bleeding risk: postoperative patients and those due to undergo an invasive procedure. Treatment decisions should be driven by clinical status, not laboratory results alone.
Treatment Approach
This protocol involves transfusion of specific blood components — selection depends on the platelet count and coagulation profile.
Exact thresholds, component choices, and full sequencing are detailed in the complete structured protocol below.
References
- Transfusion of platelets or plasma (components) in patients with DIC should not primarily be based on laboratory results and should in general be reserved for patients that present with bleeding (Grade C, Level IV).
- In patients with DIC and bleeding or at high risk of bleeding (e.g. postoperative patients or patients due to undergo an invasive procedure) and a platelet count of <50 × 10&sup9;/l, transfusion of platelets should be considered (Grade C, Level IV).
- In bleeding patients with DIC and prolonged PT and aPTT administration of FFP may be useful.
- It should not however be instituted based on laboratory tests alone but should be considered in those with active bleeding and in those requiring an invasive procedure.
DOI: 10.1111/j.1365-2141.2009.07600.x
View source ↗